Role of chronic infection and inflammation in the gastrointestinal tract in the etiology and pathogenesis of idiopathic parkinsonism. Part 2: response of facets of clinical idiopathic parkinsonism to Helicobacter pylori eradication. A randomized, double-blind, placebo-controlled efficacy study. [electronic resource]
Producer: 20051003Description: 276-87 p. digitalISSN:- 1083-4389
- Amoxicillin -- therapeutic use
- Anti-Bacterial Agents -- therapeutic use
- Anti-Ulcer Agents -- therapeutic use
- Chronic Disease
- Clarithromycin -- therapeutic use
- Double-Blind Method
- Drug Therapy, Combination
- Helicobacter Infections -- complications
- Helicobacter pylori -- drug effects
- Humans
- Inflammation
- Omeprazole -- therapeutic use
- Parkinson Disease -- drug therapy
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.